CORC

在结果中检索

CORC

浏览/检索结果: 共32条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial 期刊论文
2019, 卷号: 73, 期号: 7
作者:  Guo, Yutao;  Lane, Deirdre A.;  Wang, Liming;  Chen, Yundai;  Lip, Gregory Y. H.
收藏  |  浏览/下载：47/0  |  提交时间：2020/01/03
Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer 期刊论文
2019
作者:  Xing Puyuan;  Han Xiaohong;  Wang Sha;  Liu Yutao;  Yang Sheng
收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03
Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma 期刊论文
2019, 卷号: 9, 页码: 556
作者:  Han, Xiaohong;  Tan, Qiaoyun;  Yang, Sheng;  Li, Junling;  Xu, Jianping
收藏  |  浏览/下载：19/0  |  提交时间：2020/01/03
Prognostic significance of molecular characteristics of cerebrospinal fluid for non-small cell lung cancer patients with leptomeningeal metastasis 期刊论文
2019, 卷号: 10, 期号: 8, 页码: 1673-1682
作者:  Li, Ning;  Liu, Yutao;  Duan, Jianchun;  Yang, Boyan;  Bai, Hua
收藏  |  浏览/下载：24/0  |  提交时间：2020/01/03
Mutations in exon 8 of TP53 are associated with shorter survival in patients with advanced lung cancer 期刊论文
2019, 卷号: 18, 期号: 3, 页码: 3159-3169
作者:  Liu Yutao;  Xu Fang;  Wang Yubo;  Wu Qingchen;  Wang Buhai
收藏  |  浏览/下载：30/0  |  提交时间：2020/01/03
Clinicopathologic characteristics and outcome of patients with different EGFR mutations 期刊论文
2019, 卷号: 15, 期号: 3, 页码: 166-171
作者:  Zhou, Shengyu;  Hu, Xingsheng;  Wang, Yan;  Li, Junling;  Zhou, Liqiang
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Effectiveness of crizotinib in a patient with mesenchymal-epithelial transition overexpression/fluorescence in situ hybridization-negative/next-generation sequencing-negative advanced lung adenocarcinoma: a case report 期刊论文
2019, 卷号: 8, 期号: 2, 页码: 705-708
作者:  Song, Peng;  Liu, Li;  Liu, Yutao;  Zhang, Tao;  Guo, Lei
收藏  |  浏览/下载：63/0  |  提交时间：2020/01/03
Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors 期刊论文
2019, 卷号: 12, 期号: 1, 页码: 9
作者:  Sun, Yongkun;  Yang, Lin;  Hao, Xuezhi;  Liu, Yutao;  Zhang, Jinwen
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03
Extracellular vesicle-delivered miR-505-5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1 期刊论文
2019, 卷号: 54, 期号: 5, 页码: 1821-1832
作者:  Fang, Hua;  Liu, Yutao;  He, Yaohong;  Jiang, Yang;  Wei, Yaping
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Identification of a novel WNK1-ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib 期刊论文
2019, 卷号: 129, 页码: 92-94
作者:  Liu, Yutao;  Liu, Tianfeng;  Li, Nan;  Wang, Tao;  Pu, Yue
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace